• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

RBC starts Oracle at Neutral on competition concerns

by October 23, 2024
written by October 23, 2024

Investing.com — RBC Capital analysts initiated coverage of Oracle Corporation (NYSE:ORCL) with a Sector Perform rating and a $165 price target, expressing concerns about rising competition and the sustainability of some recent growth drivers.

“While we like Oracle’s market leadership position in database and ongoing cloud transformation, we have concerns about competition and the sustainability of some recent growth drivers, particularly OCI and GenAI,” RBC wrote.

Oracle’s core database business remains a key asset, according to the bank, but they believe it faces mounting challenges from multiple fronts.

Competition on multiple fronts continues to get stronger, including hyperscale cloud vendors (AWS/Azure/GCP), MongoDB (NASDAQ:MDB), PostgreSQL, and NewSQL vendors, RBC noted.

The firm added that while pricing may support growth, Oracle’s net new workload growth could be limited moving forward.

Oracle Cloud Infrastructure (OCI) has shown impressive growth, reaching $8.6 billion in annual recurring revenue (ARR) with a 54% growth rate, according to RBC estimates.

However, analysts remain cautious about the future of OCI.

“We have concerns over the sustainability of this growth, especially for non-Oracle customers,” RBC wrote, adding skepticism that OCI can become “the fourth hyperscaler,” especially given its much smaller size compared to competitors like AWS and Azure.

RBC also highlighted Oracle Fusion as one of the company’s more promising growth engines, particularly within financials.

“Customers view the product favorably, and partners believe the product remains ahead of the competition,” the analysts wrote. However, they expect Workday (NASDAQ:WDAY) Financials to close the gap over time.

Although the firm is bullish on generative AI (GenAI) technology, it is skeptical of Oracle’s ability to capture significant value from it.

“Our checks support our skepticism on Oracle’s GenAI announcements, especially when compared to the innovation taking place at Microsoft (NASDAQ:MSFT),” RBC noted.

With Oracle trading at all-time highs of around $175, RBC’s price target of $165 reflects a more cautious outlook, citing Oracle’s “relatively slower EPS growth” compared to peers.

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
Saudi Arabia stocks lower at close of trade; Tadawul All Share down 0.46%
next post
US existing home sales fall to 14-year low in September

You may also like

BASF results down on impairments, restructuring

January 27, 2025

European chipmakers slump as traders gauge DeepSeek AI...

January 27, 2025

Nasdaq futures tumble as China’s AI push rattles...

January 27, 2025

China Vanke’s CEO, chairman resign amid growing liquidity...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

Italy’s MPS shares fall ahead of Mediobanca board...

January 27, 2025

British Land stock drops following stake sale

January 27, 2025

UMG shares rally after new multi-year pact with...

January 27, 2025

BASF shares indicated 3% lower as impairments drag...

January 27, 2025

Ryanair cuts 2026 traffic forecast amid ongoing Boeing...

January 27, 2025
Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!








    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • China outlines more controls on exports of rare earths and technology

      October 10, 2025
    • Paramount acquires Bari Weiss’ The Free Press, naming her the top editor of CBS News

      October 7, 2025
    • YouTube to pay $24 million to settle Trump lawsuit

      October 1, 2025
    • Charlie Javice sentenced to 7 years in prison for fraudulent $175M sale of aid startup

      October 1, 2025

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (651)
    • Stock (6,426)

    Latest News

    • China outlines more controls on exports of rare earths and technology
    • Paramount acquires Bari Weiss’ The Free Press, naming her the top editor of CBS News

    Popular News

    • OpenAI considering 16 states for data center campuses as part of Trump’s Stargate project
    • Final slate of Fed speakers due before pre-meeting blackout begins

    About The Significant deals

    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy